贝那普利联合辛伐他汀治疗糖尿病肾病的临床价值分析
![]() |
第1页 |
参见附件。
摘要:目的:分析探讨贝那普利联合辛伐他汀治疗糖尿病肾病的临床疗效。
方法:选取76例糖尿病肾病患者作为研究对象,按照患者治疗方法将其分为研究组与对照组,每组38例,研究组患者行贝那普利联合辛伐他汀治疗,对照组患者仅行贝那普利治疗,比较两组患者病症改善效果。
结果:两组患者治疗后24h-UAER下降效果十分显著(P<0.05),其中研究组患者该指标改善效果明显优于对照组,组间比较差异有统计学意义(P<0.05);两组不良反应发生方面无显著差异(P>0.05)。
结论:联合贝那普利与辛伐他汀治疗糖尿病肾病可以切实患者临床病症,临床效果显著,可以推广应用。
关键词:糖尿病肾病 贝那普利 辛伐他汀 临床疗效
Doi:10.3969/j.issn.1671-8801.2014.06.024
Methods:76 cases of diabetic nephropathy patients as the research object,according topatients were divided into study group and control group,38 cases in each group,the study group were treated with Benner Pury combined simvastatin treatment,patients in the control group only received the Benner Pury treatment,compared two groups of patients with symptoms improve effect.
Result: The two groups of patients after 24h-UAER drop effect is very significant (P<; 0 ......
您现在查看是摘要介绍页,详见PDF附件。